RTTNews | Dec 1, 2021 08:23AM EST

08:22 Wednesday, December 1, 2021 (RTTNews.com) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced the launch of an authorized generic of Epiduo Forte Gel, or adapalene and benzoyl peroxide gel 0.3%/2.5%, in the U.S. It is a topical prescription medicine used to treat acne vulgaris.

The company noted that Epiduo Forte Gel had annual sales of $253 million in the U.S., according to IQVIA data, as of September 2021.

Christine Baeder, Chief Operating Officer US Generics, Teva USA, said: "Continuing to advance and launch much-needed generic drugs is critical to ensuring access to quality medicines to everyone who needs them."

Read the original article on RTTNews ( https://www.rttnews.com/3246104/teva-launches-first-to-market-authorized-generic-version-of-epiduo-forte-gel-in-the-u-s.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved